Rankings
▼
Calendar
SLNO Q4 2020 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SLNO
Soleno Therapeutics, Inc.
$2B
Q4 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$3M
EPS (Diluted)
$-0.60
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$393,000
Balance Sheet
Total Assets
$65M
Total Liabilities
$19M
Stockholders' Equity
$46M
Cash & Equivalents
$49M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$8M
-$7M
-15.7%
Net Income
-$3M
-$15M
+80.5%
← FY 2020
All Quarters
Q1 2021 →